merck germany - Search News

News

Merck KGaA, SpringWorks

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion

Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 billion, a deal that could give it access to a recently approved rare disease drug and expand its portfolio of experimental cancer treatments.

GlobalData on MSN · 16h

Merck KGaA nears $3.5bn deal for SpringWorks

Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per share.

MarketWatch · 1d

SpringWorks Therapeutics Shares Rise Following WSJ Report of Merck KGaA Deal

Shares of SpringWorks Therapeutics climbed after The Wall Street Journal reported that Germany's Merck KGaA is nearing a $3.5 billion deal for the U.S. biopharmaceutical company. SpringWorks stock rose 8.7%, to $44.80, in afternoon trading Thursday. Shares are up 2.3% in the past year.

Merck, Current US Tariffs

Reuters on MSN · 1d

Merck posts higher profit, puts tariffs cost at $200 million

Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, reflecting a January decision to pause shipments of its Gardasil vaccine to China due to a downturn in demand.

Bloomberg on MSN · 1d

Merck Expects $200 Million Hit From Current US Tariffs

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China.

The Wall Street Journal on MSN · 1d

Merck Cuts 2025 Outlook on Tariffs, Charges

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

pharmaphorum1d

Merck puts a price on its SpringWorks takeover bid

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Morningstar29d

Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug

Merck will partner with Chinese biotech Abbisko ... expanding its commercialization rights for the drug beyond Asia. The German pharmaceutical company said Friday that it would pay Abbisko an ...

Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

Newsable Asianet News on MSN1d

SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout

Shares of SpringWorks Therapeutics Inc. ended over 9% higher on Thursday following a report that the company is inching ...

Morningstar29d

Zebra Technologies and Merck KGaA, Darmstadt, Germany Collaborate to Create Safety and Traceability Solutions

This integration builds trust in AI systems regarding data authenticity and origin,” said Thomas Endress, Head of M-Trust™, Merck KGaA, Darmstadt, Germany. “Our collaboration with Zebra ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results